Essential Recombinant Human Il-36 Receptor Antagonist Protein/il-36rn/il-1f5 Perfect Gift [ITRw2yXY]

Recombinant Human IL-36 Receptor Antagonist Protein

Discover the power of our Recombinant Human IL-36 Receptor Antagonist Protein, a cutting-edge biotechnology product designed to target and modulate the IL-36 signaling pathway. This protein, also known as IL-36RN or IL-1F5, is a potent antagonist that can effectively inhibit the activity of IL-36 alpha, beta, and gamma, making it a valuable tool for research and potential therapeutic applications.

• High purity, >95% as determined by reducing SDS-PAGE.
• Low endotoxin levels, < 1.0 EU per μg of the protein.

Product Specifications and Technical Details

Our Recombinant Human IL-36 Receptor Antagonist Protein is produced in E. coli and offers a sequence covering Val2-Asp155. With a calculated molecular weight of 16.8 kDa and an observed molecular weight of 17 kDa, this protein is highly effective in inhibiting IL-36-induced IL-8 secretion in A431 human epithelial carcinoma cells.

• Expression Host: E. coli
• Sequence: Val2-Asp155
• Accession: Q9UBH0

Applications and Benefits

The Recombinant Human IL-36 Receptor Antagonist Protein is a versatile research tool with potential applications in various fields, including inflammation research and the development of novel therapeutic strategies. Its ability to specifically target and modulate the IL-36 pathway makes it a valuable asset for understanding and treating inflammatory diseases.

• Research in inflammation and immune response modulation
• Development of novel therapeutic strategies for inflammatory diseases

Whether you are a researcher or a pharmaceutical developer, this protein offers a powerful tool to advance your work and contribute to the understanding and treatment of inflammatory conditions.